Latest Advances

  • Journal: Molecules (Basel, Switzerland)
  • Published —
CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways.
  • Condition: Myositis/Myasthenia after Pembrolizumab in Patient with Bladder Cancer with an Autoimmunity-Associated HLA
  • Journal: International journal of molecular sciences
  • Treatment Used: Pembrolizumab Discontinuation, Pyridostigmine, and Steroids-Based Therapy
  • Number of Patients: 1
  • Published —
This case report describes a patient with a metastatic bladder cancer who developed myositis signs (M) and a myasthenia-like syndrome (MLS) during treatment with pembrolizumab treated with pembrolizumab discontinuation, pyridostigmine, and steroids-based therapy.
  • Condition: Muscle-Invasive Bladder Cancer (MIBC)
  • Journal: Frontiers in immunology
  • Treatment Used: Chemotherapy Combined with Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 50-year-old male diagnosed with muscle-invasive bladder cancer (MIBC) treated with chemotherapy combined with immunotherapy.
  • Condition: Intra-Abdominal Hypertension-Induced Gastroesophageal Intussusception (GEI)
  • Journal: The American journal of case reports
  • Treatment Used: Ascites Drainage
  • Number of Patients: 1
  • Published —
This case report describes an 81-year-old man who developed an intra-abdominal hypertension-induced gastroesophageal intussusception (GEI) after transurethral resection of a bladder tumor treated with ascites drainage.
  • Condition: Non-Muscle Invasive Bladder Cancer (NIMBC)
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Intravesical Gemcitabine
  • Number of Patients: 1222
  • Published —
This review of the literature assessed the effectiveness of intravesical gemcitabine instillation for the treatment of patients with non-muscle invasive bladder cancer (NMIBC).
  • Condition: Locally Advanced Prostate Cancer (LAPC) with Bladder Infiltration
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Robot-Assisted Radical Cystoprostatectomy (RARC)
  • Number of Patients: 1
  • Published —
This case report describes a 71-year-old man diagnosed with locally advanced prostate cancer (LAPC) with bladder infiltration treated with robot-assisted radical cystoprostatectomy (RARC).
  • Journal: Nature communications
  • Published —
Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex.
Showing 1-12 of 392